Cell Death and Autoimmunity

Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease

Volumn , Issue , 2006, Pages 107-137

  Casiano, Carlos A ^a   Pacheco, Fabio J ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Autoantibodies; Autoimmunity; Cell death; Immunostimulatory properties of dying cells; Impaired lymphocyte cell death and autoimmunity; Necrosis

Indexed keywords

EID: 77957929781     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527607854.ch6     Document Type: Chapter

References (192)

1. Grodzicky T, Elkon KB. Apoptosis: a case where too much or too little can lead to autoimmunity. Mt Sinai J Med. 2002; 69:208-219.
2. D'Andrea MR. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res. 2003; 982: 19-30.
3. Okada H, Mak TW. Pathways of apopto-tic and non-apoptotic death in tumour cells. Nat Rev Cancer. 2004; 4:592-603.
4. Hui H, Dotta F, Di Mario U, Perfetti R. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol. 2004; 200:177-200.
5. Chen QM, Tu VC. Apoptosis and heart failure: mechanisms and therapeutic implications. Am J Cardiovasc Drugs. 2002; 2:43-57.
6. Aigner T, Kim HA. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 2002; 46:1986-1996.
7. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med. 2000; 108:567-574.
8. Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis: basic types and mechanisms of cell death. Arch Pathol Lab Med. 1993; 117:1208-1214.
9. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Amer J Pathol. 1995; 146:3-15.
10. Guimaraes CA, Linden R. Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem. 2004; 271:1638-1650.
11. Jaattela M, Tschopp J. Caspase-independent cell death in Tlymphocytes. Nat Immunol. 2003; 4:416-423.
12. Zeiss CJ. The apoptosis-necrosis continuum: insights from genetically altered mice. Vet Pathol. 2003; 40:481-495.
13. Nicotera P. Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways. Toxicol Lett. 2002; 127:189-195.
14. Lockshin RA, Zakeri Z. Caspase-independent cell deaths. Curr Opin Cell Biol. 2002; 14:727-733.
15. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev. 2003; 17:2481-2495.
16. Kohm AP, Fuller KG, Miller SD. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol. 2003; 11:101-105.
17. Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, Houghton AN. Multiple pathways to tumor immunity and concomitant autoimmunity. Immunol Rev. 2002; 188:122-135.
18. Pollard KM, Lee DK, Casiano CA, Bluth-ner M, Johnston MM, Tan EM. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibril-larin and modifies its molecular and antigenic properties. J. Immunol. 1997; 158:3521-3528.
19. Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med. 1995; 181:1557-1561.
20. Todaro M, Zeuner A, Stassi G. Role of apoptosis in autoimmunity. J Clin Immunol. 2004; 24:1-11.
21. Mevorach D. The role of death-associated molecular patterns in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am. 2004; 30:487-504.
22. Stuart L, Hughes J. Apoptosis and auto-immunity. Nephrol Dial Transplant. 2002; 17:697-700.
23. Kuhtreiber WM, Hayashi T, Dale EA, Faustman DL. Central role of defective apoptosis in autoimmunity. J Mol Endocrinol. 2003; 31:373-399.
24. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 2003; 10:124-133.
25. Dianzani U, Chiocchetti A, Ramenghi U. Role of inherited defects decreasing Fas function in autoimmunity. Life Sci. 2003; 72:2803-2824.
26. Baker JR Jr. The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease. Thyroid. 2001; 11:245-247.
27. Pittoni V, Valesini G. The clearance of apoptotic cells: implications for autoim-munity. Autoimmun Rev. 2002; 1:154-161.
28. Rovere-Querini P, Dumitriu IE. Corpse disposal after apoptosis. Apoptosis. 2003; 8:469-479.
29. Botto M. Links between complement deficiency and apoptosis. Arthritis Res. 2001; 3:207-210.
30. Navratil JS, Sabatine JM, Ahearn JM. Apoptosis and immune responses to self. Rheum Dis Clin North Am. 2004; 30:193-212.
31. Hall JC, Casciola-Rosen L, Rosen A. Altered structure of autoantigens during apoptosis. Rheum Dis Clin North Am. 2004; 30:455-471.
32. Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 1998; 41:1152-1160.
33. Casiano CA, Ochs RL, Tan EM. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by auto-antibody probes. Cell Death Differ. 1998; 5:183-190.
34. Wu X, Molinaro C, Johnson N, Casiano CA. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthritis Rheum. 2001; 44:2642-2652.
35. Wyllie AH, Kerr JFR, Currie AC. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68:251-305.
36. Ellis RE, Yuan J, Horvitz HR. Mechanisms and function ofcell death. Annu Rev Cell Biol. 1991; 7:663-698.
37. Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction ofskin lesions and autoantibody production in LE. Lupus 1997; 6:175-180.
38. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000; 5:415-418.
39. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004; 57:1009-1014.
40. Krammer PH. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol. 1999; 71:163-210.
41. Kawanishi S, Hiraku Y. Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds. Curr Med Chem Anti-Canc Agents. 2004; 4:415-419.
42. He J, Xiao Y, Casiano CA, Zhang L. Role ofmitochondrial cytochrome c in cocaine-induced apoptosis in coronary artery endothelial cells. J Pharmacol Exp Ther. 2000; 295:896-903.
43. Oliveira MT, Rego AC, Macedo TR, Oliveira CR. Drugs ofabuse induce apopto-tic features in PC12 cells. Ann NY Acad Sci. 2003; 1010:667-670.
44. Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z. Cell signals transduced by complement. Mol Immunol. 2004; 41:583-597.
45. Andreka P, Tran T, Webster KA, Bishopric NH. Nitric oxide and promotion of cardiac myocyte apoptosis. Mol Cell Biochem. 2004; 263:35-53.
46. de Graaf AO, de Witte T, Jansen JH. Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? Leukemia. 2004; 18:1751-1759.
47. Hwang ES, Bowen PE. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food. 2004; 7:284-289.
48. Kang JH, Park YH, Choi SW, Yang EK, Lee WJ. Resveratrol derivatives potently induce apoptosis in human promyelocy-tic leukemia cells. Exp Mol Med. 2003; 35:467-474.
49. Gaipl US, Brunner J, Beyer TD, Voll RE, Kalden JR, Herrmann M. Disposal of dying cells: a balancing act between infection and autoimmunity. Arthritis Rheum. 2003; 48:6-11.
50. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000; 407:784-788.
51. Chang HY, Yang X. Proteases for cell suicide: functions and regulation of cas-pases. Microbiol Mol Biol Rev. 2000; 64:821-846.
52. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 1999; 68:383-424.
53. Denault JB, Salvesen GS. Caspases: keys in the ignition of cell death. Chem Rev. 2002; 102:4489-4500.
54. Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol. 2003; 23:317-332.
55. Ravagnan L, Roumier T, Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol. 2002; 192:131-137.
56. Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, Kroemer G. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie. 2002; 84:215-222.
57. Lorenzo HK, Susin SA. Mitochondrial effectors in caspase-independent cell death. FEBS Lett. 2004; 557:14-20.
58. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol. 2003; 195:158-167.
59. Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM, Henkart PA. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity. 1997; 6:209-215.
60. Trapani JA, Jans DA, Jans PJ, Smyth MJ, Browne KA, Sutton VR. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-de-pendent, but cell death is caspase-independent. J Biol Chem. 1998; 273:27934-27938.
61. Trapani JA, Davis J, Sutton VR, Smyth MJ. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol. 2000; 12:323-329.
62. Waterhouse NJ, Sedelies KA, Brown KA, Wowk ME, Newbold A, Sutton VR, Clarke CJ, Oliaro J, Lindemann RK, Bird PI, Johnstone RW, Trapani JA. A central role for Bid in granzyme B-induced apoptosis. J Biol Chem. 2004; 280:4476-4482.
63. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene. 2003; 22:8608-8618.
64. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003; 10:76-100.
65. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol. 2000; 62:273-295.
66. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oresic K, Turk V. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem. 2002; 383:1035-1044.
67. Stenson-Cox C, FitzGerald U, Samali A. In the cut and thrust of apoptosis, serine proteases come of age. Biochem Pharmacol. 2003; 66:1469-1474.
68. Chen Z, Casiano CA, Fletcher HM. Pro-tease-active extracellular protein preparations from Porphyromonas gingivalis W83 induce N-cadherin proteolysis, loss of cell adhesion, and apoptosis in human epithelial cells. J Periodontol. 2001; 72:641-650.
69. Jaattela M, Cande C, Kroemer G. Lyso-somes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ. 2004; 11:135-136.
70. Biggs JR, Yang J, Gullberg U, Muchardt C, Yaniv M, Kraft AS. The human brm protein is cleaved during apoptosis: the role of cathepsin G. Proc Natl Acad Sci USA. 2001; 98:3814-3819.
71. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Brede-sen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin XM, Turk V, Salvesen GS. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem. 2001; 276:3149-3157.
72. Gan L, Ye S, Chu A, Anton K, Yi S, Vincent VA, von Schack D, Chin D, Murray J, Lohr S, Patthy L, Gonzalez-Zulueta M, Nikolich K, Urfer R. Identification ofcathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach. J Biol Chem. 2004; 279:5565-5572.
73. Bidere N, Lorenzo HK, Carmona S, La-forge M, Harper F, Dumont C, Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem. 2003; 278:31401-31411.
74. Ono K, Kim SO, Han J. Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death. Mol Cell Biol. 2003; 23:665-676.
75. Bortul R, Zweyer M, Billi AM, Tabellini G, Ochs RL, Bareggi R, Cocco L, Martelli AM. Nuclear changes in necrotic HL-60 cells. J Cell Biochem. 2001; 36:19-31.
76. Rao L, Perez D, White E. Lamin proteo-lysis facilitates nuclear events during apoptosis. J Cell Biol. 1996; 135:1441-1455.
77. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res. 2003; 283:1-16.
78. Napirei M, Wulf S, Mannherz HG. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum. 2004; 50:1873-1883.
79. Kaplowitz N. Mechanisms of liver cell injury. Hepatol. 2000; 32:39-47.
80. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001; 2:589-598.
81. Chautan M, Chazal G, Cecconi F, Gruss P, Golstein P. Interdigital cell death can occur through a necrotic and caspase-in-dependent pathway. Curr Biol. 1999; 9:967-970.
82. Sapunar D, Vilovic K, England M, Sara-ga-Babic M. Morphological diversity of dying cells during regression of the human tail. Ann Anat. 2001; 183:217-222.
83. Kaneko T, Iida H, Bedford JM, Mori T. Spermatozoa of the shrew, Suncus muri-nus, undergo the acrosome reaction and then selectively kill cells in penetrating the cumulus oophorus. Biol Reprod. 2001; 65:544-553.
84. Murdoch WJ, Wilken C, Young DA. Sequence of apoptosis and inflammatory necrosis within the formative ovulatory site of sheep follicles. J Reprod Fertil. 1999;117:325-329.
85. Mayhew TM, Myklebust R, Whybrow A, Jenkins R. Epithelial integrity, cell death and cell loss in mammalian small intestine. Histol Histopathol. 1999; 14:257-267.
86. Barkla DH, Gibson PR. The fate of epithelial cells in the human large intestine. Pathology. 1999; 31:230-238.
87. Blom WM, De Bont HJ, Meijerman I, Kuppen PJ, Mulder GJ, Nagelkerke JF. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology. 1999; 29:785-792.
88. Gardiner CM, Reen DJ. Differential cyto-kine regulation of natural killer cellmediated necrotic and apoptotic cytotoxi-city. Immunology. 1998; 93:511-517.
89. Shimizu A, Masuda Y, Kitamura H, Ishi-zaki M, Ohashi R, Sugisaki Y, Yamanaka N. Complement-mediated killing of me-sangial cells in experimental glomerulo-nephritis: cell death by a combination of apoptosis and necrosis. Nephron. 2000; 86:152-160.
90. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J. Fas triggers an alternative, caspase-8-indepen-dent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000; 1:489-495.
91. Gukovskaya AS, Pandol SJ. Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology. 2004; 4:567-586.
92. Columbano A. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J. Cell. Biochem. 1995; 58:181-190.
93. Nicotera P, Leist M, Ferrando-May E. Apoptosis and necrosis: different execution of the same death. Biochem Soc Symp. 1999; 66:69-73.
94. Watson AJM. Necrosis and apoptosis in the gastrointestinal tract. Gut 1995; 37:165-167.
95. Snider BJ, Gottron FJ, Choi DW. Apoptosis and necrosis in cerebrovascular disease. Ann NY Acad Sci. 1999; 893:243-253.
96. Kelly L, Reid L, Walker NI. Massive aci-nar cell apoptosis with secondary necrosis, origin of ducts in atrophic lobules and failure to regenerate in cyanohydrox-ybutene pancreatopathy in rats. Int J Exp Pathol. 1999; 80:217-226.
97. Roy M, Sapolsky R. Neuronal apoptosis in acute necrotic insults: why is this subject such a mess? Trends Neurosci. 1999; 22:419-422.
98. Zeng YS, Xu ZC. Co-existence of necrosis and apoptosis in rat hippocampus following transient forebrain ischemia. Neurosci Res. 2000; 37:113-125.
99. Leist M, Nicotera P. The shape of cell death. Biochem Biophys Res Comm. 1997; 236:1-9.
100. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med. 1998; 187:1477-1485.
101. Michaelis M, Kotchetkov R, Vogel JU, Doerr HW, Cinatl J Jr. Cytomegalovirus infection blocks apoptosis in cancer cells. Cell Mol Life Sci. 2004; 61:1307-1316.
102. Sane AT, Bertrand R. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apop-tosis to transient G1 arrest followed by necrotic cell death. Cancer Res. 1999; 59:3565-3569.
103. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 1998; 5:298-306.
104. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S. Caspase-inde-pendent cell killing by Fas-associated protein with death domain. J Cell Biol. 1998; 143:1353-1360.
105. Denecker G, Vercammen D, Steemans M, Vanden Berghe T, Brouckaert G, Van Loo G, Zhivotovsky B, Fiers W, Grooten J, Declercq W, Vandenabeele P. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 2001; 8:829-840.
106. McCarthy NJ, Whyte MK, Gilbert CS, Evan GI. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol. 1997; 136:215-227.
107. Deas O, Dumont C, MacFarlane M, Rouleau M, Hebib C, Harper F, Hirsch F, Charpentier B, Cohen GM, Senik A. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol. 1998; 161:3375-3383.
108. Liu Y, Tergaonkar V, Krishna S, Andro-phy EJ. Human papillomavirus type 16 E6-enhanced susceptibility of L929 cells to tumor necrosis factor alpha correlates with increased accumulation of reactive oxygen species. J Biol Chem. 1999; 274:24819-24827.
109. Kitanaka C, Kuchino Y. Caspase-inde-pendent programmed cell death with necrotic morphology. Cell Death Differ. 1999; 6:508-515.
110. Fiers W, Beyaert R, Declercq W, Van-denabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 1999; 18:7719-7730.
111. Kolenko V, Uzzo RG, Bukowski R, Bander NH, Novick AC, Hsi ED, Finke JH. Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res. 1999; 59:2838-2842.
112. Melino G, Catani MV, Corazzari M, Guerrieri P, Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell Mol Life Sci. 2000; 57:612-622.
113. Smith KG, Strasser A, Vaux DL. CrmA expression in T lymphocytes of trans-genic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 1996; 15:5167-5176.
114. Boone E, Vanden Berghe T, Van Loo G, De Wilde G, De Wael N, Vercammen D, Fiers W, Haegeman G, Vandena-beele P. Structure/Function analysis of p55 tumor necrosis factor receptor and fas-associated death domain. Effect on necrosis in L929sA cells. J Biol Chem. 2000; 275:37596-375603.
115. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, Vandenabeele P. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J Exp Med. 1998; 188:919-930.
116. Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, Nagata S. Necrotic death pathway in Fas receptor signaling. J Cell Biol. 2000; 151:1247-1256.
117. Khwaja A, Tatton L. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J Biol Chem. 1999; 274:36817-36823.
118. Jones BE, Lo CR, Liu H, Srinivasan A, Streetz K, Valentino KL, Czaja MJ. He-patocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apop-tosis through caspase-dependent and caspase-independent pathways. J Biol Chem. 2000; 275:705-712.
119. Los M, Mozoluk M, Ferrari D, Step-czynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff K. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell. 2002; 13:978-988.
120. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A. 1999; 96:13978-13982.
121. Herceg Z, Wang ZQ. Failure of poly-(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol. 1999; 19:5124-5133.
122. Walisser JA, Thies RL. Poly (ADP-ri-bose) polymerase inhibition in oxidant-stressed endothelial cells prevents on-cosis and permits caspase activation and apoptosis. Exp Cell Res. 1999; 251:401-413.
123. Zhao M, Antunes F, Eaton JW, Brunk UT. Lysosomal enzymes promote mito-chondrial oxidant production, cyto-chrome c release and apoptosis. Eur J Biochem 2003; 270:3778-3786.
124. Kurz T, Leake A, von Zglinicki T, Brunk UT. Lysosomal redox-active iron is important for oxidative stress-induced DNA damage. Ann NY Acad Sci. 2004; 1019:285-288.
125. Nylandsted J, Gyrd-Hansen M, Danie-lewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M, Weber E, Multh-off G, Rohde M, Jaattela M. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med. 2004; 200:425-435.
126. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992; 356:314-317.
127. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Na-gata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the FasLigand. Cell. 1994; 76:969-976.
128. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. FasLigand mutation in a patient with systemic lupus erythe-matosus and lymphoproliferative disease.J Clin Invest. 1996; 98:1107-1113.
129. Drappa J, Kamen LA, Chan E, Georgiev M, Ashany D, Marti F, King PD. Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J Exp Med. 2003; 198:809-821.
130. Lawson BR, Baccala R, Song J, Croft M, Kono DH, Theofilopoulos AN. Text Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apop-tosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J Exp Med. 2004; 199:547-557.
131. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994; 179:1317-1330.
132. Casciola-Rosen LA, Miller DK, Anhalt G, Rosen A. Specific cleavage of the 70-kD protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem. 1994; 269:30757-30760.
133. Casciola-Rosen LA, Anhalt G, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med. 1995; 182:1625-1634.
134. Casiano CA Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med. 1996; 184:765-770.
135. Kaplan MJ. Apoptosis in systemic lupus erythematosus. Clin Immunol. 2004; 112:210-218.
136. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogen-esis of systemic autoimmune disease. Cell Death Differ. 1999; 6:6-12.
137. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA. 2002; 99:351-358.
138. Turley SJ. Dendritic cells: inciting and inhibiting autoimmunity. Curr Opin Immunol. 2002; 14:765-770.
139. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med. 1998; 188: 387-392.
140. Gensler TJ, Hottelet M, Zhang C, Schlossman S, Anderson P, Utz PJ. Monoclonal antibodies derived from BALB/c mice immunized with apopto-tic Jurkat T cells recognize known autoantigens. J Autoimmun. 2001; 16:59-69.
141. Ronchetti A, Rovere P, Iezzi G, Galati G, Heltai S, Protti MP, Garancini MP, Manfredi AA, Rugarli C, Bellone M. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol. 1999; 163:130-136.
142. Reiter I, Krammer B, Schwamberger G. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol. 1999; 163:1730-1732.
143. Barker RN, Erwig L, Pearce WP, Devine A, Rees AJ. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology. 1999; 67:302-305.
144. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immuno-stimulatory dendritic cells. J Exp Med. 2000; 191:423-434.
145. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity. 1998; 8:451-460.
146. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999; 190:815-826.
147. Ulanet DB, Flavahan NA, Casciola-Rosen L, Rosen A. Selective cleavage of nucleolar autoantigen B23 by gran-zyme B in differentiated vascular smooth muscle cells: insights into the association of specific autoantibodies with distinct disease phenotypes. Arthritis Rheum. 2004; 50:233-241.
148. Nozawa K, Casiano CA, Hamel JC, Molinaro C, Fritzler MJ, Chan EK. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res. 2002; 4(4):R3. (electronic publication)
149. Pollard KM, Pearson DL, Blüthner M, Tan EM. Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J Immunol. 2000; 165: 2263-2270.
150. Gobeil S, Boucher CC, Nadeau D, Poirier GG. Characterization of the necrotic cleavage of poly (ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 2001; 8:588-594.
151. Hu QP, Fertig N, Medsger TAJ, Wright TM. Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis. J Immunol 2004; 173:2834-2841.
152. Hu QP, Fertig N, Medsger TAJ, Wright TM. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 2003; 48:1363-73.
153. Douvas AS, Achten M, Tan EM. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979; 254:10514-10522.
154. Guldner HH, Szostecki C, Vosberg HP, Lakomek HJ, Penner E, Bautz FA. Scl 70 autoantibodies from scleroderma patients recognize a 95-kDa protein identified as DNA topoisomerase I. Chromosoma. 1986; 94:132-138.
155. Shero JH, Bordwell B, Rothfield NF, Earnshaw WC. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science. 1986; 23:737-740.
156. D'Arpa P, Machlin PS, Ratrie H, Rothfield NF, Cleveland DW, Earnshaw WC. cDNA cloning of human DNA topoisomerase I: Catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci 1988; 85:2543-2547.
157. Oriss TB, Hu PQ, Wright TM. Distinct autoreactive T cell responses to native and fragmented DNA topoisomerase I: influence of APC type and IL-2. J Immunol. 2001; 166:5456-5463.
158. Samejima K, Svingen PA, Basi GS, Kottke T, Mesner PWJ, Stewart L, Dur-rieu F, Poirier GG, Alnemri ES, Cham-poux JJ, Kaufmann SH, Earnshaw WC. Caspase-mediated cleavage of DNA to-poisomerase I at unconventional sites during apoptosis. J Biol Chem 1999; 274:4335-4340.
159. Pacheco FJ, Servin JA, Dang D, Kim J, Molinaro C, Daniels T, Brown-Bryan TA, and Casiano CA Involvement of cathepsins in the cleavage of topo-isomerase I during necrosis. Arthritis Rheum. 2005; 52:2133-2145.
160. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999; 5:1249-1255.
161. Jun JB, Kuechle M, Harlan JM, Elkon KB. Fibroblast and endothelial apopto-sis in systemic sclerosis. Curr Opin Rheumatol. 2003; 15:756-760.
162. Duthoit C, Estienne V, Giraud A, Dur-and-Gorde JM, Rasmussen AK, Feldt-Rasmussen U, Carayon P, Ruf J. Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobu-lin fragment in human thyroid cells: the onset of thyroid autoimmunity? Biochem J. 2001; 360:557-562.
163. Parnaik R, Raff MC, Scholes J. Differences between the clearance of apopto-tic cells by professional and non-professional phagocytes. Curr Biol. 2000; 10:857-860.
164. Liu H, Pope RM. Phagocytes: mechanisms of inflammation and tissue destruction. Rheum Dis Clin North Am. 2004; 30:19-39.
165. Ren Y, Savill J. Apoptosis: the importance of being eaten. Cell Death Differ. 1998; 5:563-568.
166. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apop-totic cells. J Exp Med. 2000; 191:411-416.
167. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. Homozygous C1q deficiency causes glomerulo-nephritis associated with multiple apoptotic bodies. Nat Genet. 1998; 19:596-599.
168. Mitchell DA, Taylor PR, Cook HT, Moss J, Bygrave AE, Walport MJ, Botto M. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J Immunol. 1999; 162:5676-5679.
169. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, Savill JS, Henson PM, Botto M, Walport MJ. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med. 2000; 192:359-366.
170. Gershov D, Kim S, Brot N, Elkon KB. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, sustains an antiinflammatory innate immune response. Implications for systemic autoimmunity. J Exp Med. 2000; 192:1353-1364.
171. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999; 5:694-697.
172. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001; 411:207-211.
173. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol. 1998; 161:4467-4471.
174. Rovere P, Sabbadini MG, Vallinoto C, Fascio U, Zimmermann VS, Bondanza A, Ricciardi-Castagnoli P, Manfredi AA. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells. J Leukoc Biol. 1999; 66:345-349.
175. Ip WK, Lau YL. Distinct maturation of but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J Immunol. 2004; 173:189-196.
176. Buttiglieri S, Galetto A, Forno S, De Andrea M, Matera L. Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells. Int J Cancer. 2003; 106:516-520.
177. Kotera Y, Shimizu K, Mule JJ. Comparative analysis of necrotic and apop-totic tumor cells as a source of anti-gen(s) in dendritic cell-based immunization. Cancer Res. 2001; 61:8105-8109.
178. Clayton AR, Prue RL, Harper L, Dray-son MT, Savage CO. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allo-geneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum. 2003; 48:2362-2374.
179. Brouckaert G, Kalai M, Krysko DV, Saelens X, Vercammen D, Ndlovu Haegeman G, D Herde K, Vandena-beele P. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell. 2004; 15:1089-1100.
180. Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A, Amoura Z, Piette JC, Sabba-dini MG, Rovere-Querini P, Manfredi AA. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum. 2004; 50:1549-1560.
181. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002; 418:191-195.
182. Andersson U, Tracey KJ. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheum Dis Clin North Am. 2004; 30:627-637.
183. Bianchi ME, Manfredi A. Chromatin and cell death. Biochim Biophys Acta. 2004; 1677:181-186.
184. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by ne-crotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004; 50:1861-1872.
185. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003; 425:516-521.
186. Millar DG, Garza KM, Odermatt B, Elford AR, Ono N, Li Z, Ohashi PS. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med. 2003; 9:1469-1476.
187. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med. 1998; 4:581-587.
188. Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol. 1999; 163:1398-1408.
189. Todryk SM, Melcher AA, Dalgleish AG, Vile RG. Heat shock proteins refine the danger theory. Immunology. 2000; 99:334-337.
190. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apop-totic cells and induce class I-restricted CTLs. Nature. 1998; 392:86-89.
191. Salio M, Cerundolo V, Lanzavecchia A. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur J Immunol. 2000; 30:705-708.
192. Green DR, Beere HM. Apoptosis. Gone but not forgotten. Nature. 2000; 405:28-29.